Literature DB >> 22855506

Differential RET signaling pathways drive development of the enteric lymphoid and nervous systems.

Amisha Patel1, Nicola Harker, Lara Moreira-Santos, Manuela Ferreira, Kieran Alden, Jon Timmis, Katie Foster, Anna Garefalaki, Panayotis Pachnis, Paul Andrews, Hideki Enomoto, Jeffrey Milbrandt, Vassilis Pachnis, Mark C Coles, Dimitris Kioussis, Henrique Veiga-Fernandes.   

Abstract

During the early development of the gastrointestinal tract, signaling through the receptor tyrosine kinase RET is required for initiation of lymphoid organ (Peyer's patch) formation and for intestinal innervation by enteric neurons. RET signaling occurs through glial cell line-derived neurotrophic factor (GDNF) family receptor α co-receptors present in the same cell (signaling in cis). It is unclear whether RET signaling in trans, which occurs in vitro through co-receptors from other cells, has a biological role. We showed that the initial aggregation of hematopoietic cells to form lymphoid clusters occurred in a RET-dependent, chemokine-independent manner through adhesion-mediated arrest of lymphoid tissue initiator (LTin) cells. Lymphoid tissue inducer cells were not necessary for this initiation phase. LTin cells responded to all RET ligands in trans, requiring factors from other cells, whereas RET was activated in enteric neurons exclusively by GDNF in cis. Furthermore, genetic and molecular approaches revealed that the versatile RET responses in LTin cells were determined by distinct patterns of expression of the genes encoding RET and its co-receptors. Our study shows that a trans RET response in LTin cells determines the initial phase of enteric lymphoid organ morphogenesis, and suggests that differential co-expression of Ret and Gfra can control the specificity of RET signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855506     DOI: 10.1126/scisignal.2002734

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  35 in total

Review 1.  The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut.

Authors:  Bryan B Yoo; Sarkis K Mazmanian
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

Review 2.  Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes.

Authors:  Robert O Heuckeroth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-04       Impact factor: 46.802

Review 3.  Hirschsprung's associated enterocolitis.

Authors:  Ankush Gosain; Adam S Brinkman
Journal:  Curr Opin Pediatr       Date:  2015-06       Impact factor: 2.856

Review 4.  Neuroimmune regulation during intestinal development and homeostasis.

Authors:  Henrique Veiga-Fernandes; Vassilis Pachnis
Journal:  Nat Immunol       Date:  2017-01-16       Impact factor: 25.606

Review 5.  RET revisited: expanding the oncogenic portfolio.

Authors:  Lois M Mulligan
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

Review 6.  Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.

Authors:  Alexander Drilon; Zishuo I Hu; Gillianne G Y Lai; Daniel S W Tan
Journal:  Nat Rev Clin Oncol       Date:  2017-11-14       Impact factor: 66.675

Review 7.  Cellular Organization of Neuroimmune Interactions in the Gastrointestinal Tract.

Authors:  Kara Gross Margolis; Michael David Gershon; Milena Bogunovic
Journal:  Trends Immunol       Date:  2016-06-09       Impact factor: 16.687

Review 8.  Peyer's patches: organizing B-cell responses at the intestinal frontier.

Authors:  Andrea Reboldi; Jason G Cyster
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

Review 9.  Neuro-Immune Interactions at Barrier Surfaces.

Authors:  Henrique Veiga-Fernandes; Daniel Mucida
Journal:  Cell       Date:  2016-05-05       Impact factor: 41.582

Review 10.  Emerging roles of gut microbiota and the immune system in the development of the enteric nervous system.

Authors:  Panagiotis S Kabouridis; Vassilis Pachnis
Journal:  J Clin Invest       Date:  2015-03-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.